Per- and polyfluoroalkyl substances (PFAS) have become one of the most scrutinized chemical groups in consumer products, including cosmetics. Often referred to as “forever chemicals,” PFAS are valued for their water-resistant, oil-resistant, and long-lasting properties. However, concerns about persistence in the environment and potential health risks have drawn increased regulatory attention.
Under the authority of the US FDA, and reinforced by the Modernization of Cosmetics Regulation Act (MoCRA), cosmetic manufacturers must ensure that their products are safe and properly substantiated. PFAS-related compliance has become an important focus area for cosmetic brands seeking to avoid regulatory, legal, and reputational risks.
XPRO America is a professional US FDA Consultancy supporting cosmetic companies with PFAS risk assessments, ingredient screening, safety substantiation documentation, and MoCRA-aligned compliance strategies.
What Are PFAS
PFAS (Per- and Polyfluoroalkyl Substances) are a large class of synthetic chemicals used for their resistance to heat, oil, stains, grease, and water.
In cosmetics, PFAS may be used in:
- Long-wear foundations
- Waterproof mascaras
- Lipsticks and lip liners
- Primers
- Concealers
They may be intentionally added for performance benefits or unintentionally present as contaminants.
Why PFAS in Cosmetics Is a Regulatory Concern
PFAS are highly persistent in the environment and in the human body. Some PFAS compounds have been associated with potential health concerns, including:
- Immune system effects
- Hormonal disruption
- Developmental concerns
- Certain cancers (in long-term exposure contexts)
Due to their persistence and potential toxicity, PFAS have become a major focus for regulators and policymakers.
US FDA Authority Over PFAS in Cosmetics
Currently, PFAS are not categorically banned in cosmetics at the federal level. However, the US FDA has authority to take enforcement action if:
- A cosmetic containing PFAS is deemed unsafe
- A product is adulterated
- Adequate safety substantiation cannot be demonstrated
Under MoCRA, companies must maintain adequate safety substantiation for all ingredients, including PFAS.
MoCRA and PFAS Safety Substantiation
MoCRA requires cosmetic companies to maintain scientific evidence demonstrating that each product is safe for its intended use.
For PFAS-containing products, safety substantiation should include:
- Identification of specific PFAS compounds used
- Toxicological assessment
- Exposure evaluation
- Risk characterization
- Contaminant testing data
Failure to maintain proper documentation may lead to US FDA record requests or enforcement action.
XPRO America prepares safety substantiation dossiers tailored to PFAS risk profiles.
State-Level PFAS Restrictions
While federal law may not fully prohibit PFAS in cosmetics, several US states have enacted restrictions or bans on certain PFAS uses in cosmetic products.
This creates a complex compliance landscape where companies must evaluate:
- Federal US FDA requirements
- State-level restrictions
- Retailer requirements
- International regulations
XPRO America assists companies in harmonizing compliance across jurisdictions.
Intentional vs. Unintentional PFAS
PFAS may enter cosmetics through:
- Intentional addition for product performance
- Impurities in raw materials
- Contamination during manufacturing
Even unintentional contamination may raise regulatory concerns.
Supplier qualification and testing programs are critical.
Testing and Analytical Considerations
Companies should consider:
- Targeted PFAS testing
- Broad-spectrum screening
- Supplier certificates of analysis
- Raw material risk assessments
Laboratory testing methods must be appropriate for cosmetic matrices.
Labeling and Transparency Risks
PFAS may appear in ingredient lists under chemical names that include “fluoro,” “perfluoro,” or “polyfluoro.”
Misleading claims such as “PFAS-free” must be substantiated and accurate.
False or misleading labeling can result in misbranding violations under US FDA regulations.
Enforcement Risks Under US FDA Authority
If PFAS presence leads to safety concerns, the US FDA may:
- Issue warning letters
- Request safety documentation
- Initiate product sampling
- Mandate recalls under MoCRA
- Take seizure action
Strong preventive compliance reduces enforcement risk.
Business and Reputational Considerations
PFAS-related litigation and consumer awareness have increased significantly.
Risks include:
- Product liability lawsuits
- Retailer delisting
- Consumer trust erosion
- Investor scrutiny
Proactive PFAS risk management protects brand reputation.
Preventive Compliance Strategy
To manage PFAS-related risk, companies should:
- Screen ingredient lists for PFAS compounds
- Review supplier documentation
- Conduct contaminant testing
- Maintain robust safety substantiation
- Monitor state regulatory developments
- Work with an experienced US FDA Consultancy
How XPRO America Supports PFAS Compliance
XPRO America operates as a trusted US FDA Consultancy providing:
- PFAS ingredient screening
- Safety substantiation documentation
- Supplier compliance assessment
- Regulatory risk analysis
- Labeling compliance review
- MoCRA compliance support
- Multi-state regulatory monitoring
For professional assistance, contact support@xproamerica.com.
Strategic Regulatory Outlook
PFAS in cosmetics represents a rapidly evolving regulatory and compliance area. While not universally banned at the federal level, PFAS usage is under increasing scrutiny by regulators, lawmakers, and consumers.
With expert guidance from XPRO America, cosmetic companies can proactively manage PFAS-related risk, maintain strong safety documentation, and operate confidently within US FDA regulatory expectations.
Leave a Reply